NCT01405040

Brief Summary

The primary objective of this study is to obtain the TPTD, GEDV and EVLW measurements from existing indwelling femoral arterial Volume View™ catheter and central venous catheters.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
97

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2010

Shorter than P25 for all trials

Geographic Reach
2 countries

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

July 20, 2011

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 29, 2011

Completed
Last Updated

April 4, 2013

Status Verified

April 1, 2013

Enrollment Period

11 months

First QC Date

July 20, 2011

Last Update Submit

April 1, 2013

Conditions

Keywords

CardiacOutputPreloadLungWater

Outcome Measures

Primary Outcomes (1)

  • TPTD, GEDV and EVLW measurements to evaluate the precision and accuracy of a novel algorithm in comparison to the widely accepted TPTD method

    This is not an outcome study. This is an observational Study to obtain TPTD, GEDV and EVLW data to evaluate the precision and accuracy of a novel algorithm in comparison to the widely accepted TPTD method using an approach defined by Bland-Altman.

    Up to 72 hours of femoral arterial catheter dwell time.

Study Arms (1)

EV1000 Observational Group

Patient must have an indwelling femoral arterial catheter and central venous catheter considered necessary for routine clinical monitoring; Patient, or legal guardian, will give consent prior to study enrollment and data capture; Patient must be at least 18 years old; Patient height and weight are available prior to study.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will include all ICU patients requiring cardiac preload and lung water assessment.

You may qualify if:

  • Patient must have clinical need for an indwelling femoral arterial catheter and central venous catheter.
  • Patient, or legal guardian, must sign consent to be in the study prior to data capture.
  • Patient must be at least 18 years old.
  • Patient height and weight are available prior to study.

You may not qualify if:

  • Patients with significant aortic valve regurgitation.
  • Patients being treated with an intra-aortic balloon pump.
  • Patients less than 40 kg in weight.
  • Female patients with a known pregnancy or planned pregnancy.
  • Patient is currently participating in an investigational drug or another device study that clinically interferes with the study endpoints.
  • Patients with peripheral vascular disease.
  • Patients with aortic aneurysm.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Universitätsklinikum der RWTH Aachen

Aachen, Pauwelsstrasse 30, 52074, Germany

Location

Der Rheinischen Friedrich-Wilhelms-Universität Bonn

Bonn, Sigmund Freud Strasse 25, 53105, Germany

Location

Stadtspital Triemli Zürich

Zurich, Birmensdorferstr 497, 8063, Switzerland

Location

HUG-Hôpitaux Universitalres de Genève

Geneva, Canton of Geneva, 1211, Switzerland

Location

Related Publications (2)

  • Bendjelid K, Marx G, Kiefer N, Simon TP, Geisen M, Hoeft A, Siegenthaler N, Hofer CK. Performance of a new pulse contour method for continuous cardiac output monitoring: validation in critically ill patients. Br J Anaesth. 2013 Oct;111(4):573-9. doi: 10.1093/bja/aet116. Epub 2013 Apr 26.

  • Kiefer N, Hofer CK, Marx G, Geisen M, Giraud R, Siegenthaler N, Hoeft A, Bendjelid K, Rex S. Clinical validation of a new thermodilution system for the assessment of cardiac output and volumetric parameters. Crit Care. 2012 May 30;16(3):R98. doi: 10.1186/cc11366.

Study Officials

  • Dana Deyette, RN, CCRP

    Edwards Lifesciences LLC

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 20, 2011

First Posted

July 29, 2011

Study Start

January 1, 2010

Primary Completion

December 1, 2010

Study Completion

December 1, 2010

Last Updated

April 4, 2013

Record last verified: 2013-04

Locations